Abstract:Ye Zhao, 1, &ast Xi Chen, 1, &ast Yuhan Huang, 2, &ast Zhihan Zhang, 3 Kui Wang, 1 Duowu Zou, 1 Teng Ma 2 1 Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 2 Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China; 3 Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Teng Ma, Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China, Email Duowu Zou, Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China, Email Purpose: This study aimed to investigate gene expression profiles, identify potential hub genes, and predict drugs for patients with erosive esophagitis (EE). Despite its clinical significance, molecular-level exploration of this condition has been limited. Patients and Methods: RNA sequencing was performed on clinical biopsy samples from eight EE patients and eight healthy controls. Integrated bioinformatic tools were then utilized to analyze the data, including functional enrichment analysis, protein-protein interaction network analysis, weighted gene co-expression network analysis, immune infiltration analysis, and identification of small-molecule compounds. Additionally, the expressions of the identified hub genes were assessed in clinical samples. Results: A total of 2801 genes with differential expression were identified, including four potential hub genes: SOX9, SPP1, TIMP1, and TLR4. Moreover, the overexpression of these hub genes was verified in clinical samples. Analysis of Immune infiltration indicated an imbalance in the distribution of immune cell types in patients with EE. Correlation analysis between immune cells and hub genes unveiled noteworthy relationships. Specifically, SOX9 exhibited a negative correlation with CD8 T cells but a positive correlation with resting memory CD4 T cells. SPP1 displayed a positive correlation with naïve B cells, while TIMP1 exhibited a negative correlation with resting dendritic cells. Furthermore, the study identified ten small-molecule drugs with potential therapeutic effects for EE, including loreclezole and mercaptopurine. Conclusion: This study provides valuable insights into the molecular understanding of EE, offering new perspectives on disease mechanisms. The findings may inspire further research leading to the development of novel treatment strategies for EE. Keywords: erosive esophagitis, RNA sequencing, bioinformatics analysis, immune infiltration, drug prediction Gastroesophageal reflux disease (GERD) is widely considered the most prevalent digestive disorder among adults, posing a significant public health issue. 1,2 Patients with GERD commonly manifest symptoms such as distressing heartburn, effortless regurgitation, and additional complications, causing challenges in clinical management. 3 A recent systematic review of nearly one hundred studies revealed its worldwide average prevalence of 13.3%. 4 GERD has two primary subtypes, non-erosive reflux disease (NERD) and erosive esophagitis (EE), mainly based on the presence or absence of macroscopic erosions. 5 By performing endoscopy, clinicians can diagnose GERD patients with esophageal mucosal breaks or ulcerations as having EE and grade its severity from A (mild) to D (severe) according to the Los Angeles (LA) classification system. 6,7 The understanding of the pathogenesis of GERD has undergone a significant transformation from a conventional "top-down" model to the later "bottom-up" concept, commonly referred to as the "cytokine sizzle". 8,9 The theory of cytokine-driven mucosal injury suggests that cytokine secretion triggered by reflux sets in motion the development of esophagitis. 9 The esophageal mucosa acts as the first defense against the noxious refluxate, playing a pivotal role in the pathogenesis of GERD. Recent advances in exploring how the aggressive components of the refluxate lead to mucosal inflammation have contributed to the current integrated view of pathogenesis of GERD mucosa, which includes changes in the permeability of the esophageal epithelial barrier, activation of nociceptive nerves, and inflammation mediated by cytokines. 9 Heterogeneity of reflux components and causal factors can af -Abstract Truncated-

Esophageal Epithelium and Lamina Propria are Unevenly Involved in Eosinophilic Esophagitis.

Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis

Characterization of lamina propria remodeling in pediatric eosinophilic esophagitis using second harmonic generation microscopy

Mucosal Microbiota Associated With Eosinophilic Esophagitis and Eosinophilic Gastritis

Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis

Development and dysfunction of structural cells in eosinophilic esophagitis

Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies

Transnasal Endoscopy Acquires Esophageal Biopsies Adequate for Comprehensive Pathology Evaluation in Patients With Eosinophilic Esophagitis

Persistent desmoglein-1 downregulation and periostin accumulation in histologic remission of eosinophilic esophagitis

A Multicenter Long-Term Cohort Study Of Eosinophilic Esophagitis Variants And Their Progression To Eoe Over Time

In vivo Raman spectroscopy reveals biochemical composition of the esophageal tissue in pediatric eosinophilic esophagitis.

Mononuclear cell composition and activation in blood and mucosal tissue of eosinophilic esophagitis

An esophagus cell atlas reveals dynamic rewiring during active eosinophilic esophagitis and remission

Monitoring and modulating the trajectory of eosinophilic esophagitis

Clinical Characteristics, Endoscopic Findings, and Treatment Outcomes in Lymphocytic Esophagitis Compared to Eosinophilic Esophagitis

Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes

Expression of Immunoglobulin G4 in Eosinophilic Esophagitis

Transcriptomic Insights into Hub Genes, Immune Infiltration, and Candidate Drugs in Erosive Esophagitis

The Minimally Invasive 1-Hr Esophageal String Test (EST) Monitors Therapeutic Changes in Mucosal Inflammation in Eosinophilic Esophagitis

S617 Poor Correlation Between Esophageal Distensibility and Symptoms in Eosinophilic Esophagitis (EoE)

Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study